ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

Live-attenuated strains of simian immunodeficiency virus (SIV) routinely confer apparent sterilizing immunity against pathogenic SIV challenge in rhesus macaques. Understanding the mechanisms of protection by live-attenuated SIV may provide important insights into the immune responses needed for pro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Michael D Alpert, Jackson D Harvey, W Anderson Lauer, R Keith Reeves, Michael Piatak, Angela Carville, Keith G Mansfield, Jeffrey D Lifson, Wenjun Li, Ronald C Desrosiers, R Paul Johnson, David T Evans
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS Pathogens
Online Access:	https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1002890&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SIV vpx is essential for macrophage infection but not for development of AIDS.
by: Susan V Westmoreland, et al.
Published: (2014-01-01)

Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge.
by: Arun K Sasikala-Appukuttan, et al.
Published: (2013-01-01)

Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.
by: Sama Adnan, et al.
Published: (2016-12-01)

Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques
by: Jessica Coppola, et al.
Published: (2025-06-01)

Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection.
by: Haiying Li, et al.
Published: (2014-12-01)

Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
by: Benjamin Varco-Merth, et al.
Published: (2024-08-01)

Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques.
by: Caroline Soulas, et al.
Published: (2015-01-01)

A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation.
by: Panagiotis Vagenas, et al.
Published: (2010-09-01)

Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.
by: Daniel Mendoza, et al.
Published: (2013-02-01)

Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.
by: Binhua Ling, et al.
Published: (2014-01-01)

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.
by: Hugh C Welles, et al.
Published: (2022-06-01)

Deep analysis of CD4 T cells in the rhesus CNS during SIV infection.
by: Sonny R Elizaldi, et al.
Published: (2023-12-01)

Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry.
by: Rachid Sougrat, et al.
Published: (2007-05-01)

Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques.
by: Daniel R Ram, et al.
Published: (2018-05-01)

Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.
by: Eugene V Barsov, et al.
Published: (2011-01-01)

Testing Device for Metro Vehicle SIV Controller
by: YU Chang-chao, et al.
Published: (2013-01-01)

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
by: Fredrik Barrenäs, et al.
Published: (2021-07-01)

SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
by: Omotayo Farinre, et al.
Published: (2025-01-01)

A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection.
by: Scott P Lawrence, et al.
Published: (2022-06-01)

Fragmentation of SIV-gag vaccine induces broader T cell responses.
by: Adel Benlahrech, et al.
Published: (2012-01-01)

Persistent innate immune dysfunction and ZIKV replication in the gastrointestinal tract during SIV infection in pigtail macaques
by: Jennifer Tisoncik-Go, et al.
Published: (2025-03-01)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
by: Michael W Grunst, et al.
Published: (2023-05-01)

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.
by: Rosemarie D Mason, et al.
Published: (2016-05-01)

Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection.
by: David Favre, et al.
Published: (2009-02-01)

Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure.
by: Tommi A White, et al.
Published: (2010-12-01)

Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS.
by: Jennifer H Campbell, et al.
Published: (2011-04-01)

SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells
by: Narmada Sambaturu, et al.
Published: (2025-05-01)

Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir.
by: Taina T Immonen, et al.
Published: (2021-06-01)

Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
by: Sarah J Byrnes, et al.
Published: (2023-03-01)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.
by: Moritz Ries, et al.
Published: (2017-07-01)

Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo?
by: Marjet Elemans, et al.
Published: (2011-09-01)

Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization.
by: Sharon Lederer, et al.
Published: (2009-02-01)

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection
by: Srivamshi Pittala, et al.
Published: (2019-05-01)

Multi-omics analysis of SIV-specific CD8+ T cells in multiple anatomical sites.
by: Jennifer Simpson, et al.
Published: (2024-09-01)

Pre-challenge gut microbial signature predicts RhCMV/SIV vaccine efficacy in rhesus macaques
by: Hayden N. Brochu, et al.
Published: (2024-11-01)

Attenuated Disease in SIV-Infected Macaques Treated with a Monoclonal Antibody against FasL
by: Maria S. Salvato, et al.
Published: (2007-01-01)

Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
by: Nami Iwamoto, et al.
Published: (2021-01-01)

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
by: Brandon F Keele, et al.
Published: (2024-04-01)

Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapy.
by: Chad R Wells, et al.
Published: (2021-06-01)

CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells.
by: Luca Micci, et al.
Published: (2014-10-01)